Sunshine Biopharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/20/2024 | Q2 2024 | -$9.94 | $9.30 M | |||
| 05/20/2024 | Q1 2024 | -$40.04 | $7.54 M | |||
| 03/28/2024 | Q4 2023 | -$104.69 | $7.68 M | |||
| 11/13/2023 | Q3 2023 | -$50.72 | $5.96 M | |||
| 08/10/2023 | Q2 2023 | -$0.71 | $5.56 M | |||
| 05/10/2023 | Q1 2023 | -$154.51 | $4.89 M | |||
| 12/31/2022 | Q4 2022 | -$1.05 | $3.94 M | |||
| 11/07/2022 | Q3 2022 | -$7.71 | $132,808 | |||
| 08/03/2022 | Q2 2022 | -$2.41 | $150,307 | |||
| 05/06/2022 | Q1 2022 | -$7.82 | $122,645 | |||
| 03/21/2022 | Q4 2021 | $0.65 | $85,118 | |||
| 11/09/2021 | Q3 2021 | -$26.48 | $50,376 | |||
| 08/09/2021 | Q2 2021 | -$20.06 | $52,874 | |||
| 05/11/2021 | Q1 2021 | -$46.99 | $40,058 | |||
| 03/30/2021 | Q4 2020 | -$6.43 | $28,013 | |||
| 11/10/2020 | Q3 2020 | -$4.15 | $17,150 | |||
| 08/19/2020 | Q2 2020 | -$3.48 | $15,145 | |||
| 05/18/2020 | Q1 2020 | -$0.50 | $11,102 | |||
| 04/30/2020 | Q4 2019 | -$2.11 | $10,556 | |||
| 11/13/2019 | Q3 2019 | -$2.12 | $7,326 |
Sunshine Biopharma, Inc. Earnings: Frequently Asked Questions
-
How can I listen to Sunshine Biopharma, Inc.'s earnings conference call?
The conference call for Sunshine Biopharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Sunshine Biopharma, Inc.'s conference call transcript?
The conference call transcript for Sunshine Biopharma, Inc.'s latest earnings report can be read online.
-
How much revenue does Sunshine Biopharma, Inc. generate each year?
Sunshine Biopharma, Inc. (:SBFMW) has a recorded annual revenue of $24.09 M.
-
How much profit does Sunshine Biopharma, Inc. generate each year?
Sunshine Biopharma, Inc. (:SBFMW) has a recorded net income of $24.09 M. Sunshine Biopharma, Inc. has generated $-370.41 earnings per share over the last four quarters.
-
What is Sunshine Biopharma, Inc.'s price-to-earnings ratio?
Sunshine Biopharma, Inc. (:SBFMW) has a price-to-earnings ratio of -0.04 and price/earnings-to-growth ratio is -0.
